We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cocoa Flavonols Increase Blood Flow to Brain

By Biotechdaily staff writers
Posted on 11 Aug 2005
Molecules called flavonols found in cocoa and dark chocolate have demonstrated to be not only healthy for the heart but may also influence blood flow to the brain, according to a new study.

This study may have implications for the ability to treat strokes, diabetes, and vascular dementia, and the data could soon be available to pharmaceutical companies for development into new medications, according to researchers. More...


Prof. Ian MacDonald, professor of physiology at the University of Nottingham (UK), reported that he and coworkers have discovered that cocoa flavonols could increase blood flow to major areas of the brain. In a study of 16 healthy young women, the scientists studied the brain's activation during cognitive tasks using functional magnetic resonance imaging (fMRI).

"The mounting scientific evidence on cocoa flavonols is extraordinary,” said Dr. Norm Hollenberg, professor of Medicine at Harvard Medical School (Boston, MA, USA), and one of the first scientists to discover the potential health benefits of cocoa flavonols. "This is a scientific breakthrough that could well lead to a medical breakthrough.”

Furthermore, researchers at Mars, Inc. (Mount Olive, NJ, USA), a leading candy manufacturer, have found that entire "libraries” of cocoa flavanols can be manufactured, and that new flavanols can be developed from natural flavonols, enhancing their viability for use in pharmaceutical medications. The research was discussed among international researchers at a meeting sponsored by Mars, which has conducted cocoa studies for more than 15 years. The meeting was held in July 2005 in Lucerne (Switzerland).

Prof. MacDonald reported that further studies should evaluate whether flavonols could help individuals who are tired or for people with mild cognitive problems. This increase in blood flow could result from a vascular effect, according to Prof. MacDonald.
In the Nottingham study, the participants consumed the flavonol-rich CocoaVia drink, produced by Mars, once a day for five days before the start of the study. The drink contains 150 mg of flavonols. Earlier studies demonstrated that cocoa flavonols appear to increase nitric oxide synthesis by the blood vessels, thereby increasing blood flow.

At the meeting, investigators at the University Hospital (Zurich, Switzerland) and Harvard Medical School also reported that similar increases in blood flow can be achieved among individuals with diabetes. This suggests that cocoa flavonols could help in treating acute vascular complications associated with long-term diabetes.





Related Links:
University of Nottingham

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.